Addex Partner Starts First-Ever Clinical Trial Of An MGluR Positive Allosteric Modulator

Posted by admin on June 25th, 2009 in Medical Devices

Allosteric modulation company Addex Pharmaceuticals (SWISS: ADXN) announced today that its partner Ortho-McNeil- Janssen Pharmaceuticals Inc. (OMP) has started Phase I testing of ADX71149, a metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator (PAM). This product, which has potential to treat schizophrenia, anxiety, depression and other CNS disorders, is the first PAM of any mGluR [...]

Comments Off

ACOG Refines Fetal Heart Rate Monitoring Guidelines

Posted by admin on June 25th, 2009 in Medical Devices

Refinements of the definitions, classifications, and interpretations of fetal heart rate (FHR) monitoring methods were issued today in new guidelines released by The American College of Obstetricians and Gynecologists (ACOG). The objective of the guidelines is to reduce the inconsistent use of common terminology and the wide variability that sometimes occurs in FHR interpretations.

Comments Off